Resonance Health Limited - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Resonance Health Limited. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Resonance Health Limited. The Group's principal activities are developing and commercializing of technologies for the quantitative analysis of radiological images. Its core product is FerriScan, a liver diagnostic technology used for the measurement of iron overload in the liver. It uses a computer software to analyze data obtained through magnetic resonance imaging (MRI). The Group operates within Australia and the United States of America.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report